ArticleJournal of ultrasound2026
Ultrasound findings across liver fibrosis stages defined by transient elastography in patients with chronic hepatitis B in Georgia.
Article in Journal of ultrasound, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
purposeChronic hepatitis B (CHB) remains a major cause of chronic liver disease and may progress to liver fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). This study aimed to evaluate conventional abdominal ultrasound (US) findings across liver fibrosis stages defined by transient elastography (TE) in patients with CHB.
methodsIn this cross-sectional study, 232 adults with CHB were included. Conventional abdominal US and TE data were available for 231 patients. US findings were evaluated in relation to liver fibrosis stages defined by TE-derived liver stiffness measurements. Differences in liver stiffness according to US findings were assessed using the independent-samples t-test.
resultsPatients with heterogeneous liver echotexture had significantly higher liver stiffness than those with normal liver echotexture (8.71 ± 6.89 vs. 5.65 ± 1.30 kPa; mean difference, 3.06 kPa; 95% CI 1.78-4.34 kPa; p < 0.001). Patients with splenomegaly had significantly higher liver stiffness than those without splenomegaly (17.31 ± 15.18 vs. 6.55 ± 2.82 kPa; mean difference, 10.77 kPa; 95% CI 2.00-19.54 kPa; p = 0.020). Among the 231 patients, 71.9% were classified as F0-F1, 21.6% as F2-F3, and 6.5% as F4. Four patients were diagnosed with HCC, including three with cirrhosis (F4) and one with F0-F1 fibrosis.
conclusionsConventional abdominal US findings, particularly heterogeneous liver echotexture and splenomegaly, were associated with higher liver stiffness in patients with CHB. These findings support the complementary role of conventional abdominal US in the comprehensive non-invasive evaluation of patients with CHB.
Indexed as
Identifiers
42860455What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.